How RISC Works: Argonaute, Small RNAs, and the Logic of Gene Silencing

 

A mechanistic guide to RISC assembly, guide-strand selection, target recognition, slicing, repression, deadenylation, and turnover.

Argonaute and RISC: The Molecular Engine Behind RNA Interference

RISC components: The core RISC is a small-RNA-loaded Argonaute (AGO) protein, often associated with GW182/TNRC6 in animals. In metazoans, Dicer and its dsRNA-binding cofactors (TRBP/PACT in mammals; R2D2/Loqs in flies) form a RISC-loading complex (RLC) that hands off small-RNA duplexes to Argonaute. Argonaute contains four domains (N, PAZ, MID, PIWI) that bind the 3' end, 5' end, and body of the guide.

Small-RNA biogenesis/loading: miRNAs derive from Pol II hairpins (pri-miRNAs) processed by Drosha/DGCR8 and then Dicer into ∼22-nt duplexes. siRNAs come from long dsRNA (viral or endogenous) cleaved by Dicer. piRNAs are Dicer-independent ~24-30-nt RNAs from single-stranded precursors (e.g. in germline) loaded into Piwi-clade AGOs. After biogenesis, small-RNA duplexes are loaded into AGO (with Hsc70/Hsp90 chaperones). Guide strand selection depends on 5'-end nucleotide preference and thermodynamic asymmetry, and the passenger strand is removed by Argonaute slicing (if fully complementary) or a "slicer-independent" unwinding mechanism.

Argonaute conformational states: Crystal/cryo-EM structures show AGO as a bilobed protein (MID-PIWI lobe and N-PAZ lobe) that clamps the guide (5' end in the MID pocket, 3' end in PAZ). Loading and target-binding trigger conformational shifts: apo-AGO "open" state, guide-bound "clamped" state, and target-bound state in which the central channel widens to accommodate guide-target pairing. The N-domain helps splay duplex strands and limits 3'-target pairing (enforcing seed-based recognition).

Guide selection & passenger removal: After loading, AGO uses multiple "sensors" to choose the guide strand. Factors include 5'-terminal nucleotide identity (MID pocket preference), thermodynamic stability of ends, and Ago's slicing of the passenger if perfectly paired. In slicer-competent AGOs (e.g. human AGO2, Drosophila AGO2), the passenger strand can be cleaved (at the guide's 10-11 position) to free the guide. Non-slicing AGOs or imperfect duplexes rely on thermal destabilization plus chaperones (e.g. C3PO, La/SSB) to unwind and eject the passenger. Open questions include the exact roles of unwinding factors (C3PO, etc.) and how different AGO isoforms manage strand separation.

Target recognition: The core determinant of target binding is seed pairing: perfect complementarity to guide positions 2-7 (or 8) drives binding. Additional base-pairing 3' of the seed (supplementary pairing) strengthens binding, while central mismatches/bulges generally prevent slicing. Bulged or wobbled sites can still mediate repression if seed pairing is intact. The tolerance of mismatches and the extent of supplementary pairing vary with AGO clade and species. Outstanding questions include the full rules for non-seed interactions and how AGO conformational changes propagate mismatch signals (cf. Joseph & Osman 2012).

Catalytic cleavage: Only AGOs with an active RNase H-like "PIWI" domain can slice targets. Human AGO2 (and, to a lesser extent, AGO3) carry the catalytic DEDH tetrad required for Mg²+-dependent phosphodiester hydrolysis. Cleavage chemistry resembles RNase H: the guide-bound AGO positions the scissile phosphate near two Mg²+ ions, facilitating an SN2 attack by the 2'-OH on the adjacent phosphate. Structures (e.g. human Ago2-miRNA-target complexes) show a kink at the cleavage site induced by the so-called "glutamate finger", orienting the water nucleophile. Open issues include the detailed energetics of catalysis and how slicer-inactive AGOs function in organisms like plants (some plant AGOs have lost slicing yet still mediate silencing).

Translational repression & deadenylation: In animals, AGO-guide complexes recruit GW182/TNRC6 proteins, which in turn bind poly(A)-binding protein (PABP) and the CCR4-NOT and PAN2-PAN3 deadenylase complexes. This leads to shortening of the poly(A) tail, decapping (via DCP1/2), and mRNA decay. miRNA-bound AGO may also inhibit translation initiation (via eIF4G/eIF4A interference). Key experiments tethering GW182 to reporters demonstrate that GW182 alone can induce deadenylation and repression. In flies, loss of GW182 abolishes deadenylation but has complex effects on translational repression. Open questions include how GW182 distinguishes targets for decay vs mere repression, and how initial translation inhibition is triggered prior to mRNA decay.

RISC recycling/turnover: After target repression or cleavage, RISCs must be recycled for further rounds. Target cleavage yields 5' and 3' fragments; recent work suggests phosphorylative events promote release of cleaved products (e.g. AGO2 C-terminal serine phosphorylation accelerates target release). The "loading" AGO may remain bound to the guide for multiple cycles. Small RNAs themselves can turnover (some miRNAs are stabilized by 2'-O-methylation in plants and animals). Factors like XRN1 exonuclease clear cleaved targets. A notable factor, C3PO, degrades AGO-nicked passenger fragments to fully activate RISC. Precisely how AGOs dissociate from targets for new rounds (and how Ago itself is turned over or modified) are active research areas.

Regulatory PTMs and cofactors: AGO function is modulated by post-translational modifications. Human AGO2 is phosphorylated at several sites: for example, Y393 by EGFR (in hypoxia) reduces AGO2-Dicer binding and miRNA loading; S387 by Akt3 promotes recruitment of LIMD1/TNRC6A and DDX6 into repression complexes; a C-terminal S824-S834 cluster is hyperphosphorylated after target binding to accelerate target release. Other PTMs include AGO2 sumoylation, acetylation, ubiquitination, prolyl-4-hydroxylation, and PARylation, many of which affect stability or localization. RISC cofactors include heat-shock chaperones (Hsc70/Hsp90) required for loading duplexes, the C3PO nuclease (for passenger removal), and RNA helicases (e.g. MOV10, to disrupt RNPs). Open questions include the full map of AGO modifications in various cell states and how co-chaperones influence loading kinetics.

Experimental evidence: The RISC mechanism is supported by multiple assay types. X-ray crystallography and cryo-EM have resolved Argonaute structures in apo, guide-bound, and guide-target states (e.g. archaeal and bacterial Argonautes; eukaryotic Ago2-miRNA complexes; TNRC6-AGO complexes). In vitro cleavage assays (radioactive RNA substrates) defined the catalytic "slicer" requirements and rates. Crosslinking immunoprecipitation (CLIP) sequencing (HITS-CLIP, PAR-CLIP, CLASH) have mapped AGO binding sites transcriptome-wide, confirming seed-pairing rules and identifying non-canonical sites. Luciferase reporter assays with inserted miRNA sites have quantified repression efficiency and defined seed/supplement categories. Cryo-EM of the human RISC-loading complex (Ago2-Dicer-TRBP) has recently illuminated loading intermediates.

Open questions/controversies: Despite progress, some issues remain unresolved. The relative contributions of translational repression vs mRNA decay in different contexts is debated. The existence and mechanism of miRNA "target slicing" (beyond perfect siRNA-like sites) is still being explored. The roles of many AGO co-factors (beyond Dicer/TRBP, GW182) are still being delineated. Structural snapshots capture many states, but the dynamic transitions of AGO during target search are less understood. Finally, the diversity of AGO family members (with different activities) raises questions about their specialized functions in various species and pathways.

Argonaute	Domain architecture	Active-site motif	Slicer?	Major pathway/notes
HsAGO1	N–PAZ–MID–PIWI (858 aa)	DEDH (E remains)	No	miRNA repression
HsAGO2	N–PAZ–MID–PIWI (859 aa)	DEDH (canonical)	Yes	miRNA/siRNA (viral)
HsAGO3	N–PAZ–MID–PIWI (925 aa)	DEDH (mutant form)	Marginal¹	miRNA (some slicing)
HsAGO4	N–PAZ–MID–PIWI (859 aa)	DEDN (N instead of H)	No	miRNA
DmAGO1	N–PAZ–MID–PIWI (843 aa)	DEDH (E remains)	No	miRNA (development)
DmAGO2	N–PAZ–MID–PIWI (940 aa)	DEDD (active)	Yes	siRNA antiviral
CeRDE-1	N–PAZ–MID–PIWI (925 aa)	DEDH (active)	Yes	siRNA (RNAi)
Piwi proteins (e.g. HsHIWI2)	N–PAZ–MID–PIWI (1000+ aa, plus Gly-rich N-term)	DEDH / DEDH	Yes (piRNA)	germline piRNA silencing

RISC Composition and Assembly

The core of RISC is an Argonaute protein bound to a single-stranded "guide" RNA. In animals, GW182/TNRC6 proteins (with tandem GW/WG motifs) bind AGO and mediate repression/decay. In the RISC-loading complex, AGO is physically associated with Dicer and its dsRNA-binding partners: in mammals, Dicer binds TRBP and/or PACT; in Drosophila, Dcr-2 binds R2D2 (and Loquacious). These scaffolds bring the small-RNA duplex to AGO. Biochemically, purified human Dicer-TRBP and Dicer-PACT complexes each form stable RLCs that bind siRNA or pre-miRNA; swapping TRBP and PACT domains can alter processing specificity. Notably, RLC assembly increases Dicer's affinity for RNA and presents the duplex in a conformation competent for loading.

During loading, ATP-dependent chaperones (Hsc70/Hsp90, Hop, p23, etc.) are required to "open" AGO for duplex entry. In vitro reconstitution (purified components) shows that Hsp90beta, Hsc70 and cochaperones form a loading machine that presents AGO in a high-affinity state for the duplex. Inhibition of Hsp90 blocks RISC loading in cells, indicating this is a conserved requirement (Tomari & Zamore 2005; Tahbaz et al. 2005). After AGO binds the duplex (one strand destined as guide, the other passenger), a series of strand-separation steps ensues (see below). Only after passenger ejection is the RISC considered mature and able to bind targets.

Table 1 (below) compares selected Argonaute proteins: all share N, PAZ, MID, PIWI domains (N-box and PAZ grip the duplex; MID anchors the guide's 5'-phosphate; PIWI harbors the RNaseH fold). The presence of an active-site Asp/Glu (the "slicer tetrad") determines whether a given AGO can catalyze target cleavage. For example, human AGO2 has the canonical DEDH and is an active slicer, whereas AGO1/3/4 have substitutions (AGO3 can be activated by domain swaps). Organismal distribution varies: many animals encode multiple AGO paralogs (e.g. 4 in humans, each broadly expressed), while plants have >10 AGOs with specialized roles.

Small-RNA Biogenesis and Loading

miRNA Pathway

Animal miRNAs begin as long primary transcripts (pri-miRNAs) made by Pol II. The Microprocessor complex (Drosha + DGCR8) cleaves the pri-miRNA into a ~60-70-nt precursor hairpin (pre-miRNA). This pre-miRNA is exported to the cytoplasm and further diced by Dicer into a ~22-nt RNA duplex with 2-nt 3' overhangs. TRBP and PACT (humans) or Loquacious (flies) bind Dicer's RNase III domains and influence cleavage accuracy and strand selection. The guide strand selection is influenced by 5'-terminal nucleotide preference (AGO MID-domain often favors U or A) and by the relative thermodynamic stability of the duplex ends. The duplex (with 5'-monophosphates on both strands) is presented to AGO: in humans this usually means AGO2, while other AGOs also bind miRNAs but are non-slicing. Chaperone proteins (Hsc70/Hsp90) use ATP to transiently "open" AGO for duplex entry.

siRNA Pathway

siRNAs arise from long double-stranded RNAs (exogenous viruses, transposons, or endogenous transcripts). In Drosophila, Dicer-2 (with partner R2D2) processes long dsRNA into 21-nt siRNA duplexes. In mammals, a single Dicer can generate both miRNAs and siRNAs (e.g. from shRNA expression) with the help of TRBP/PACT. Once produced, siRNA duplexes are loaded into AGO. In flies, AGO2 is specialized for siRNAs; in mammals, AGO2 is the main slicer and can load siRNAs for RNAi. A key feature of siRNA loading is that one strand (the guide) will pair fully with targets, so AGO can cleave complementary mRNA targets.

piRNA Pathway (brief)

In metazoan germlines, piRNAs are 24-30 nt RNAs that associate with PIWI-clade Argonautes (Piwi, Aubergine, AGO3 in flies; PIWIL1-4 in mammals). piRNAs derive from single-stranded cluster transcripts (no Drosha/Dicer required). Mitochondrial endonuclease Zucchini (and Tudor-domain factors) generate primary piRNAs. Ping-pong amplification creates secondary piRNAs via slicer activity of PIWI proteins. The final piRNA-Piwi complexes mediate transposon silencing by target cleavage and transcriptional repression (H3K9 methylation). piRNA 5' ends are 2'-O-methylated by Hen1, further stabilizing them. (See Iwasaki et al. 2015 for review.)

Loading and Strand Separation

In all pathways, after duplex production the RLC loads the duplex into AGO. AGO's MID domain "senses" the 5'-phosphate of one strand to position it as the guide. The other strand (passenger) must be removed. Two mechanisms operate:

Slicer-assisted: If the passenger strand is fully complementary, AGO2 (or other slicers) will cleave it between positions 10-11 (guide numbering). This "nick" promotes rapid dissociation of the passenger fragments. This is the case for siRNAs in canonical RNAi. Matranga et al. (2005) showed that human and fly AGO2 cleaves the passenger of loaded siRNA, while miRNA duplexes (imperfect) are not cleaved.

Slicer-independent: Non-slicing AGOs (e.g. AGO1, 3, 4) or imperfect duplexes rely on the intrinsic thermodynamic bias (less stable 5' end or mismatches) to eject the passenger. At 37°C human AGO1/3/4 can eject an siRNA passenger without cleavage, suggesting a "hotter" conformational dynamics (the PAZ domain transiently releases the 3' end). Accessory factors like C3PO (a Mg²+-dependent endonuclease) can degrade nicked passenger fragments, further promoting activation. La/SSB has also been reported to bind AGO2 and assist release of cleavage products. Thus, even without slicing, AGO can effect strand separation through conformational changes and ancillary helpers.

Open questions remain about the precise kinetics of passenger removal (e.g. how general is C3PO's role?) and how AGOs discriminate guide vs passenger beyond thermodynamics.

Argonaute Structure and Guide/Target Interactions

Argonaute proteins are bilobed. The MID-PIWI lobe forms one side of the nucleic-acid channel, the PAZ-N lobe forms the other (Figure 1 in). The MID domain (Rossmann-like fold) binds the 5'-phosphate and first base of the guide by a conserved pocket. The PAZ domain (OB-fold) binds the 2-nt 3' overhang of the guide. Thus the guide is anchored at both ends. The N-terminal "N domain" lies between the lobes and helps split duplexes and prevent overextension of base-pairing at the guide's 3' end. The PIWI domain is a RNase H-like fold containing the (Asp/Glu) active site. The catalytic tetrad (Asp-Glu-Asp-His) coordinates two Mg²+ ions for phosphodiester hydrolysis. (Non-slicer AGOs have one or more mutations in this motif.)

As shown by crystal structures, AGO-guide interactions define a characteristic "seed channel". Positions 2-8 of the guide (the seed) are pre-organized by contacts to the protein (e.g. MID/PAZ interactions clamp the ends). The N-PAZ lobe covers the 3' half of the guide, preventing pairing until the seed has bound. Upon target binding, structures show the seed region bound to target, inducing a kink at position 6-7. With extensive pairing beyond position 8, the guide-target duplex can extend into the supplementary chamber of the PIWI lobe. The transition from guide-only to guide-target causes conformational shifts: in some cases the PIWI domain repositions its active site loop (the "glutamate finger") to engage the scissile phosphate.

Conformational studies (FRET, cryo-EM) indicate at least three AGO states: apo-open (RNA-free), guide-loaded (central cleft clamped), and target-bound (cleft open to accommodate duplex). The MID and PIWI domains move closer upon guide binding, completing the GW182-binding surface. These structural rearrangements enforce the target recognition rules: only targets pairing to the seed (g2-7/8) can productively bind deep in the channel. Mismatches/bulges in the seed severely weaken binding (seed is base-paired in helix). In contrast, central mismatches (guide 9-11) prevent slicing by misaligning the active site. Supplementary pairing (guide 13-17) can strengthen binding if present. Figures 2-3 in Uchiumi et al. (2016) and structures in illustrate the guide and target path.

Target Recognition Rules

AGO-guide complexes scan mRNAs for complementary sequences. The seed region (guide positions 2-7/8) is paramount: a contiguous Watson-Crick match here is usually required for stable binding. Typical miRNA target sites are classified as 6mer (nts 2-7), 7mer (2-8), or 8mer (2-8+matching A at target position 1) in 3'UTRs. Additional "3'-supplementary" pairing (guide 13-17 to target positions) can compensate for a shorter seed. Many bona fide sites tolerate a single bulge or GU wobble in the seed if flanked by perfect pairs. However, a mismatch at guide position 9/10 (the scissile phosphate) abolishes cleavage.

Genome-wide CLIP-seq experiments (e.g. AGO HITS-CLIP by Chi et al. 2009, Helwak et al. 2013) confirm that 3'UTR sites with canonical seed pairing (often with flanking AU-rich context) are enriched under AGO peaks. Non-canonical sites (seedless or centered sites) exist but are generally weaker. AGO's N-domain can sometimes tolerate small 3'-bulges of the guide, but extended bulges usually require an extra stabilizing anchor (e.g. 3' supplementary pairing) to engage the PIWI lobe. Mutational studies show that introducing bulges in the seed disrupts silencing regardless of downstream pairing.

A remaining mystery is how AGOs detect and "communicate" guide-target mismatches. Molecular dynamics studies suggest an allosteric network within AGO relays information from the seed to the catalytic site and to surface sites. For example, Joseph & Osman (2012) found that seed mismatches induce small shifts in an extensive residue network, ultimately affecting surface loops. In practice, mismatches reduce slicing efficiency and accelerate turnover, but non-slicing repression can still occur (with reduced potency).

Catalytic (Slicer) Cleavage Mechanism

When a target pairs fully to the guide (especially positions 2-12), slicing occurs (in slicing-competent AGOs). The PIWI domain's RNase H fold positions two divalent cations (Mg²+) near the guide-target junction. One metal activates a water nucleophile for in-line attack on the scissile phosphate, while the other stabilizes the leaving group. The conserved glutamate finger (a loop in PIWI) contacts the phosphate backbone to position the scissile bond at the catalytic center. Structural studies of archaeal Ago and human Ago2 (bound to guide and target) reveal the cleavage geometry: the target's phosphodiester is bent at the cleavage site and the 2'-OH of the target attacks the phosphorus, yielding 5'-phosphate and 3'-OH ends.

Biochemical kinetics show slicer cleavage is single-turnover fast (∼minutes) when complementarity is perfect, and essentially abrogated by mismatches or bulges at the cleavage site. Mutagenesis of the DEDH residues (e.g. D597A, H807A in hAGO2) completely blocks cleavage but not binding. For non-slicer AGOs (lacking the full tetrad), target binding still occurs but no phosphodiester bond breakage ensues - these RISCs rely entirely on repression/deadenylation pathways.

Recent cryo-EM data (e.g. Cell 2025 by Zhang et al.) have begun to capture the intermediate states of human AGO2 during cleavage, revealing how the active site reorganizes. The precise catalytic mechanism (e.g. transition state intermediates) likely parallels RNase H enzymes. Open questions include the pH dependence and any required proton transfers, and how AGO3 (with variant PIWI) may occasionally cleave unusual substrates.

Translational Repression and Deadenylation

In metazoans, most miRNA binding triggers repression rather than cleavage. The bridge between AGO and the repression machinery is provided by GW182/TNRC6 proteins. GW182 proteins have an N-terminal AGO-binding region (with multiple tryptophan "GW" motifs) and a C-terminal effector region that interacts with mRNA decay factors. Tethering experiments (GW182 fused to a reporter) show that GW182 alone can induce poly(A) shortening and translational silencing.

Mechanistically, AGO-GW182 complexes recruit PABP and the CCR4-CAF1-NOT deadenylase and PAN2-PAN3 complexes to the target mRNA tail. The deadenylases shorten the poly(A) tail, which leads to decapping by DCP1/2 and 5'->3' exonucleolytic decay (XRN1). GW182 also interacts with DDX6 (RCK/p54) and other decapping enhancers. In Drosophila, knocking down CCR4 or NOT1 abolishes miRNA-dependent deadenylation and decay, but residual translational repression can persist. Thus, translational repression can be mechanistically separated from deadenylation, though in cells they often occur sequentially.

Proposed models for repression include interference with cap recognition or ribosome initiation. For example, GW182-bound CCR4-NOT can inhibit eIF4A/eIF4G, blocking 43S pre-initiation complex assembly. Some data suggest miRNA-mediated repression acts primarily at initiation, while others find elongation stalls or ribosome drop-off. The field agrees that deadenylation is a major downstream effect, but the timing (repression first, decay later) is still debated.

In summary, after target binding the mature RISC can silence expression by (1) slicing (if perfect match, via PIWI), or (2) recruiting GW182 to repress translation and deadenylate/decap the mRNA. The balance of these pathways depends on AGO isoform, target context, and cell type.

RISC Recycling and Turnover

Once an mRNA is cleaved or repressed, the question arises: how is the AGO-guide complex recycled? Cleavage case: Argonaute slices the target, leaving two fragments. These fragments dissociate from AGO (AGO then remains bound to the guide). Recent evidence suggests AGO2 is actively phosphorylated after target binding to promote release: phosphorylation of its C-terminal serine cluster (S824-S834) lowers the affinity for bound mRNA, allowing AGO to turn over more rapidly. Conversely, preventing this phosphorylation leads to "sticky" RISC that holds onto targets. Thus, an AGO phosphorylation cycle accelerates RISC recycling after slicing.

Repression case: If no slicing occurred, AGO stays bound to target 3' UTR. It likely releases by thermal dissociation (since pairing is partial) or with help from RNA helicases (e.g. MOV10) and ATPases (e.g. Me31b/DDX6). Notably, TNRC6 can bind multiple RISCs to one mRNA, possibly stabilizing some interactions. Eventually, after multiple rounds of repression/decay, the RISC may dissociate or be sequestered into P-bodies.

RISC turnover: Argonaute itself is relatively stable (half-lives of many hours) but is turned over by ubiquitination (especially AGO2) under some conditions. Stress or viral infection can trigger Argonaute degradation. Small RNAs also turn over: 3' end 2'-O-methylation in plants and piRNAs protects them from exonucleases. In animals, the lack of 2'-O-methylation in AGO-loaded miRNAs may make them susceptible to tailing and trimming (via TUTases and exonucleases), particularly for aged RISC.

Finally, after mRNA decay, the guide strand itself may be released from AGO and degraded, freeing AGO to load a new duplex. The details of guide recycling are less well studied, but in vitro slicing assays show that AGO2-guide can survive multiple cleavage events.

Regulatory PTMs and Cofactors

AGO activity is finely tuned by post-translational modifications and binding partners:

Phosphorylation: As noted, AGO2 undergoes key phosphorylations. EGFR (under hypoxia) phosphorylates AGO2 at Y393, which disrupts AGO2-Dicer interaction and downregulates miRNA maturation. Serine phosphorylation of AGO2 is rich: S387 (by Akt3 kinase) triggers AGO2 binding to LIMD1 and recruitment of TNRC6A and DDX6, coupling miRNA repression to the CCR4-NOT complex. A C-terminal cluster S824-S834 is phosphorylated upon target binding, lowering mRNA affinity (as above). Other kinases (CK1alpha, GRK4) also modify AGO2 at distinct sites, altering localization (nuclear vs cytoplasmic) or miRNA loading. Overall, phosphorylation regulates when and where RISC binds targets and recruits repressors.

Other PTMs: AGO2 is SUMOylated (on Lys402) to enhance stability and localization to P-bodies. Kinetic studies show SUMOylation can switch AGO2 between translational repression vs slicing modes. Lys48-linked polyubiquitination leads to proteasomal turnover of AGO. Prolyl-4-hydroxylation (on a conserved Pro700 in human AGO2) is important for miRNA activity in tumor cells. PARP enzymes can ADP-ribosylate AGO2, antagonizing its function during stress. These modifications often respond to signaling pathways, linking RISC activity to cellular state.

Cofactors: We have already mentioned Dicer/TRBP/PACT and Hsc70/Hsp90 as loading cofactors. Other notable partners include: (1) C3PO (TREX1 complex) that degrades AGO2-nicked passenger RNAs to finalize RISC activation (Ye et al., 2011). (2) La/SSB binds AGO2 and promotes release of cleaved fragments. (3) MOV10 helicase associates with AGO2-miRNA complexes and is thought to remodel target mRNPs for degradation. (4) GW182-binding factors: LIMD1 (in complex with AKT3) and FMRP/FXR1 may scaffold repression complexes.

Open areas include: How the interplay of these modifications is orchestrated (e.g. does Akt3 phosphorylation always precede AGO2-GW182 binding?), and whether there are uncharacterized AGO partners in specialized RNP granules (e.g. germ granules, stress granules).

Key Experimental Evidence

Structural studies: High-resolution crystal structures of Argonautes (bacterial, archaeal, eukaryotic) have defined the domain architecture and guide/target path. Song et al. (2004) and Nishimasu et al. (2012) solved human AGO2 with guide RNA. More recent cryo-EM (Sheu-Gruttadauria et al. 2019, Ma 2021) captured human AGO-guide complexes at different steps. Structures of AGO with GW182 peptides (Sheu-Gruttadauria et al. 2019) reveal the tryptophan-binding pockets on PIWI. These static images, combined with single-molecule FRET, illuminate how AGO opens/closes during loading and target scanning.

Biochemical assays: Slicing activity has been assayed with radio-labeled target RNAs, establishing that only AGO2 (and AGO3 with modifications) can cut. Mutational scanning of the seed region (by Oglesbee, La Rocca, etc.) mapped the exact base-pairing requirements for repression vs cleavage. Reconstitution of RISC in vitro (Doudna lab) with purified human proteins showed that an RLC of Dicer-TRBP-Ago2 suffices for efficient loading and cleavage of complementary targets (Noland & Doudna 2013). Tethering GW182 to a reporter demonstrated that CCR4-NOT recruitment alone can silence translation without AGO (Eulalio et al. 2009).

High-throughput target identification: HITS-CLIP and PAR-CLIP of AGO proteins (Hafner et al. 2010; Chi et al. 2009) identified thousands of binding sites, refining seed-match rules. CLASH (crosslinking ligation and sequencing) captured chimeric reads of miRNA-target hybrids (Helwak et al. 2013), revealing non-canonical sites and miRNA sponges. Ribosome profiling experiments (e.g. Guo et al. 2010, Eichhorn et al. 2016) showed that mRNA decay is the dominant outcome of miRNA action, supporting the model that repression precedes deadenylation and decay.

Functional reporters: Hundreds of studies using luciferase or GFP reporters with synthetic miRNA sites (seed matches, bulged sites, etc.) have empirically measured repression efficiency. Such assays confirmed the hierarchy of site types (8mer>7mer-A1>7mer-m8>6mer) and showed that supplemental 3' pairing boosts repression of 6mers (Brennecke et al. 2005).

Each of these assays underpins the mechanistic model: structural data define the molecular contacts; in vitro assays reveal the chemistry; and genomic experiments validate the rules in cells.

Pathway	Small RNA	Size (nt)	Precursor/Processing	Key AGO effector	Mode of action
miRNA	miR, miR* duplex	~22	pri-miR –(Drosha)→ pre-miR –(Dicer)→ duplex【18†L1942-L1948】	hAGO1–4 (AGO2 slicer)	Seed pairing → translational repression & decay【33†L262-L270】
siRNA	siRNA duplex	21–23	long dsRNA –(Dicer)→ duplex (TRBP/PACT or R2D2–Dicer)【23†L263-L271】	hAGO2, DmAGO2	Full pairing → target cleavage (slicer)
piRNA	piRNA	26–31	single-strand transcript –(Zucchini + ping-pong)→ piRNA【56†L113-L121】	Piwi-clade (Aub, Piwi)	Transposon silencing by cleavage and heterochromatin

References:

Perspective: machines for RNAi. Genes and Development, 2005. https://doi.org/10.1101/gad.1284105

Origins and Mechanisms of miRNAs and siRNAs. Cell, 2009. https://pmc.ncbi.nlm.nih.gov/articles/PMC2675692/

Towards a molecular understanding of microRNA-mediated gene silencing. Nature Reviews Genetics, 2015. https://www.nature.com/articles/nrg3965

The Structure of Human Argonaute-2 in Complex with miR-20a. Cell, 2012. https://doi.org/10.1016/j.cell.2012.05.017

Structural basis for microRNA targeting. Science, 2014. https://pubmed.ncbi.nlm.nih.gov/25359968/

From guide to target: molecular insights into eukaryotic RNA-interference machinery. Nature Structural and Molecular Biology, 2015. https://www.nature.com/articles/nsmb.2931

Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nature Reviews Genetics, 2008. https://www.nature.com/articles/nrg2455